• Treating Neurodegenerative Diseases with Rob Etherington, CEO of Clene Nanomedicine

  • Apr 24 2024
  • Duración: 26 m
  • Podcast

Treating Neurodegenerative Diseases with Rob Etherington, CEO of Clene Nanomedicine Por arte de portada

Treating Neurodegenerative Diseases with Rob Etherington, CEO of Clene Nanomedicine

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • Listen in on our conversation with Rob Etherington, CEO of Clene Nanomedicine, a company pioneering nanotherapeutics for neurodegenerative diseases like ALS, multiple sclerosis, and Parkinson's.

    Rob discusses Clene's unique approach to improve mitochondrial function through a novel nanotherapeutic called CNM-au8, which has shown promising outcomes in clinical trials. He highlights the challenges in drug development, including funding and FDA approval processes, and underscores the importance of resilience, continuous learning, and strategic partnerships in advancing biotech innovations. The episode also touches on Rob's personal philosophy on leadership and the importance of women in leadership roles.

    https://clene.com/
    https://www.linkedin.com/in/rob-etherington-431718/

    Qualio website:
    https://www.qualio.com/

    Previous episodes:
    https://www.qualio.com/from-lab-to-launch-podcast

    Apply to be on the show:
    https://forms.gle/uUH2YtCFxJHrVGeL8

    Music by keldez
    Más Menos
activate_primeday_promo_in_buybox_DT
Liderazgo Economía Ciencias Biológicas
Más Menos

Lo que los oyentes dicen sobre Treating Neurodegenerative Diseases with Rob Etherington, CEO of Clene Nanomedicine

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles